Robert A. Michael is a seasoned executive who currently serves as the President and Chief Operating Officer at AbbVie Inc., a global biopharmaceutical company. With a robust background in the healthcare and pharmaceutical industries, Michael has been instrumental in steering AbbVie towards significant growth and innovation. He joined AbbVie in 2013, following the company's spin-off from Abbott Laboratories, and has since held various leadership positions within the organization. In his current role as President and COO, Michael oversees AbbVie's global commercial operations, which span across numerous therapeutic areas, including immunology, oncology, and neuroscience. His strategic vision and operational expertise have been pivotal in expanding AbbVie's product portfolio and enhancing its market presence worldwide. Under his leadership, AbbVie has successfully launched several blockbuster drugs and has continued to invest heavily in research and development to address unmet medical needs. Prior to joining AbbVie, Michael held several key positions at Abbott Laboratories, where he honed his skills in business development and operations. His career is marked by a series of notable achievements, including driving the successful commercialization of innovative therapies and leading cross-functional teams to achieve corporate objectives. Robert A. Michael's dedication to advancing healthcare and his ability to navigate complex market dynamics make him a vital asset to AbbVie and the broader biopharmaceutical industry.